These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5564305)

  • 21. Biochemical evidence for a distinct type of primary gout.
    Sorensen LB; Benke PJ
    Nature; 1967 Mar; 213(5081):1122-3. PubMed ID: 6029792
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term treatment of gout with "allopurinol".
    Michotte JL; Burtonboy G
    Acta Rheumatol Scand; 1968; 14(1):71-8. PubMed ID: 5649436
    [No Abstract]   [Full Text] [Related]  

  • 24. Basic sciences in medicine: the example of gout.
    Stetten D
    N Engl J Med; 1968 Jun; 278(24):1333-6. PubMed ID: 5648600
    [No Abstract]   [Full Text] [Related]  

  • 25. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 26. Purine metabolism in women with primary gout.
    Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of allopurinol (4-hydroxyprazolo(3,4-d)pyrimidine) on xanthine accumulation by milk xanthine oxidase in vitro.
    Jezewska MM
    Eur J Biochem; 1974 Jul; 46(2):361-5. PubMed ID: 4408204
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs and uric acid.
    Rundles RW; Wyngaarden JB
    Annu Rev Pharmacol; 1969; 9():345-62. PubMed ID: 4953095
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of allopurinol in relation to purine biosynthesis.
    Hitchings GH
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):601-7. PubMed ID: 5335281
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of glucose infusion on the renal transport of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Higashino K
    Nephron; 1995; 69(4):424-7. PubMed ID: 7777107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
    HALL AP; HOLLOWAY VP; SCOTT JT
    Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
    [No Abstract]   [Full Text] [Related]  

  • 33. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

  • 34. Depletion of erythrocyte phosphoribosylpyrophosphate in man.
    Fox IH; Wyngaarden JB; Kelley WN
    N Engl J Med; 1970 Nov; 283(22):1177-82. PubMed ID: 4319625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Allopurinol].
    Scott JT
    Schweiz Med Wochenschr; 1967 Dec; 97(49):1659-62. PubMed ID: 5596893
    [No Abstract]   [Full Text] [Related]  

  • 37. The development of allopurinol.
    Rundles RW
    Arch Intern Med; 1985 Aug; 145(8):1492-503. PubMed ID: 3896181
    [No Abstract]   [Full Text] [Related]  

  • 38. Xanthine-containing calculi during allopurinol therapy.
    Kranen S; Keough D; Gordon RB; Emmerson BT
    J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and biological aspects of dyspurinia with enzyme deficiency].
    Kaplan G
    Pathol Biol (Paris); 1970 Oct; 18(19):881-6. PubMed ID: 4922808
    [No Abstract]   [Full Text] [Related]  

  • 40. Xanthine oxidase deficiency: studies of a previously unreported case.
    Holmes EW; Mason DH; Goldstein LI; Blount RE; Kelley WN
    Clin Chem; 1974 Aug; 20(8):1076-9. PubMed ID: 4369449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.